DaVita Overview
Compare DaVita's DCF valuation ($300) to today's market price.
Get informed when a big investor buys or sells
+ Follow$302.49
Undervalued by 69.5% based on the discounted cash flow analysis.
DaVita (DVA) currently reports a DCF fair value of $300. Use the charts on this page to explore DaVita's DCF fair value history and peer comparisons.
DaVita's discounted cash flow (DCF) fair value estimate is $300, about 69.5% undervalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $300, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DaVita, and consider following DVA for alerts when major investors trade the stock.
DaVita is classified in the Healthcare sector. On DCF fair value, it currently shows $300. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DVA with unrelated industries.
